Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

Harbeck, Nadia; von Schumann, Raquel; Kates, Ronald Ernest; Braun, Michael; Kuemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; De Haas, Sanne Lysbet; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich; Gluz, Oleg

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2022-02-07T09:36:14Z
dc.date.available	2022-02-07T09:36:14Z
dc.date.issued	2021
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/124086
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers13194884	de_DE
dc.subject.ddc	610	de_DE
dc.title	Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20211125174918_00420
utue.personen.roh	Harbeck, Nadia
utue.personen.roh	von Schumann, Raquel
utue.personen.roh	Kates, Ronald Ernest
utue.personen.roh	Braun, Michael
utue.personen.roh	Kuemmel, Sherko
utue.personen.roh	Schumacher, Claudia
utue.personen.roh	Potenberg, Jochem
utue.personen.roh	Malter, Wolfram
utue.personen.roh	Augustin, Doris
utue.personen.roh	Aktas, Bahriye
utue.personen.roh	Forstbauer, Helmut
utue.personen.roh	Tio, Joke
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Biehl, Claudia
utue.personen.roh	Liedtke, Cornelia
utue.personen.roh	De Haas, Sanne Lysbet
utue.personen.roh	Deurloo, Regula
utue.personen.roh	Wuerstlein, Rachel
utue.personen.roh	Kreipe, Hans Heinrich
utue.personen.roh	Gluz, Oleg
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 4884	de_DE
dcterms.isPartOf.ZS-Volume	13 (19)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE